Results 61 to 70 of about 3,072 (115)

Unveiling the interoception impairment in various major depressive disorder stages

open access: yesCNS Neuroscience &Therapeutics, Volume 30, Issue 8, August 2024.
In this study, interoception impairments, beginning in MDD's preclinical phase and escalating during its clinical stage, were found to predictively impact all primary symptom clusters, particularly emotional symptoms. Internal validation underscored their significant role in improving diagnostic accuracy and predictive capabilities for MDD, which ...
Hongliang Zhou   +9 more
wiley   +1 more source

Pharmacological Studies with Nialamide, A New Antidepressant Agent

open access: yesExperimental Biology and Medicine, 1959
SummaryNialamide was a potent monoamine oxidase inhibitor by both in vitro and in vivo test. Its potency relative to that of iproniazid varies from 3:1 to 12:1 depending on test and species used. Nialamide was also shown to be qualitatively different from other MAO inhibitors in some of its pharmacological actions, factors which may explain absence of ...
S. Y. P'An   +3 more
openaire   +3 more sources

Resocialization mitigates depressive behaviors induced by social isolation stress in mice: Attenuation of hippocampal neuroinflammation and nitrite level

open access: yesBrain and Behavior, Volume 14, Issue 6, June 2024.
Abstract Background and aim Social isolation stress (SIS) is a stressor known to trigger depressive behaviors. Psychiatric disorders are associated with neurobiological changes, such as neuroinflammation and an increase in nitric oxide (NO) signaling. Despite the well‐established detrimental effects of SIS and the involvement of neuroinflammation and ...
Hossein Amini‐Khoei   +2 more
wiley   +1 more source

Interventions for treating depression after stroke [PDF]

open access: yes, 2008
Background: Depression is an important consequence of stroke that impacts on recovery yet is often not detected or inadequately treated. This is an update of a Cochrane review first published in 2004.
Agnoli   +254 more
core   +1 more source

ROLE OF COPPER AND KETAMINE IN MAJOR DEPRESSIVE DISORDER - AN UPDATE [PDF]

open access: yes, 2019
Major depressive disorder is one of the most important psychiatric issues worldwide, with important prevalence of treatmentresistant depression (TRD). Non-monoaminergic agents are currently in the spotlight. Objective was to explore for information about
Cubała, Wiesław Jerzy   +10 more
core   +1 more source

Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report [PDF]

open access: yes, 2002
BACKGROUND: Hepatotoxicity is one of the most serious complications of highly active antiretroviral therapy (HAART). The aim of this report is to analyse an HIV infected patient on HAART including nevirapine and taking antidepressive agents, with acute ...
Gökengin, Deniz, Yamazhan, Tansu
core   +3 more sources

Efeitos da fluoxetina sobre a ultraestrutura mitocondrial no ventrículo direito de ratos expostos ao estresse pelo frio [PDF]

open access: yes, 2009
OBJECTIVE: To assess fluoxetine effects on mitochondrial structure of the right ventricle in rats exposed to cold stress. METHODS: The experimental study procedures were performed in 250-300g male EPM-Wistar rats.
Abreu, Luiz Carlos de   +7 more
core   +3 more sources

Volume Five Subject Index [PDF]

open access: yes, 1969
Subject index for MCV/Q, Medical College of Virginia Quarterly, Volume ...

core   +1 more source

Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder [PDF]

open access: yes, 2011
Background There is emerging evidence that antidepressants may be effective in preventing patients with non-specific and psychotic-like prodromal symptoms, defined as patients at ultra-high risk (UHR) of psychotic disorder, from transitioning to ...
Hashimoto, Kenji   +4 more
core   +3 more sources

Effect of Unrestricted Access to Running Wheels on Cancer-Related Fatigue [PDF]

open access: yes, 2011
Cancer-related fatigue (CRF) occurs in 60-90% of cancer patients and significantly reduces functional status. Tumor growth causes significant wasting of skeletal muscle, thought to be a major factor in CRF.
Little, Courtney
core  

Home - About - Disclaimer - Privacy